Indoco Remedies gets two minor observations from USFDA for Goa plants

New Delhi: Drug firm Indoco Remedies Thursday said it has received two minor observations from the US health regulator for its Goa-based two plants. The US Food and Drug Administration (USFDA) inspected the manufacturing facilities between November 14-21.

“The inspection concluded with the company receiving two minor observations, none of which are repeat in nature,” Indoco Remedies said in a regulatory filing.

Indoco said it is in the process of responding to the observations within the stipulated time of 15 days, it added.

The facility had earlier received a warning letter from the USFDA in March 2017.

“This positive development will now pave the way for approval of our pending ANDAs with consequent boost to revenues from the US market,” Indoco Remedies Managing Director Aditi Kare Panandikar said.

Headquartered in Mumbai, Indoco Remedies has nine manufacturing facilities and has presence across 55 countries.

Shares of the company Thursday ended 20 per cent up at Rs 206.40 on the BSE.

  • Related Posts

    • Pharma
    • July 24, 2025
    • 193 views
    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

    • Pharma
    • July 22, 2025
    • 276 views
    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra